FTSE All-Share
5.326,71
PKT
+11,13
PKT
+0,21
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.03.14 | Diageo Neutral | JP Morgan Chase & Co. | |
| 20.03.14 | London Stock Exchange (LSE) Neutral | JP Morgan Chase & Co. | |
| 19.03.14 | AstraZeneca Halten | Independent Research GmbH | |
| 19.03.14 | Barclays overweight | JP Morgan Chase & Co. | |
| 19.03.14 | GSK Hold | Jefferies & Company Inc. | |
| 19.03.14 | Barclays buy | Deutsche Bank AG | |
| 19.03.14 | HSBC Underperform | Credit Suisse Group | |
| 18.03.14 | Vodafone Group Buy | UBS AG | |
| 18.03.14 | Vodafone Group Hold | S&P Capital IQ | |
| 18.03.14 | Shell (ex Royal Dutch Shell) Hold | Deutsche Bank AG | |
| 18.03.14 | BP buy | Deutsche Bank AG | |
| 17.03.14 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 17.03.14 | Rio Tinto buy | UBS AG | |
| 17.03.14 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 17.03.14 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 17.03.14 | AstraZeneca Neutral | BNP PARIBAS | |
| 17.03.14 | Glencore Outperform | BNP PARIBAS | |
| 14.03.14 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 14.03.14 | Shell (ex Royal Dutch Shell) Hold | Société Générale Group S.A. (SG) | |
| 14.03.14 | Sky buy | UBS AG | |
| 14.03.14 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 14.03.14 | Barclays buy | Nomura | |
| 13.03.14 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.03.14 | GSK Hold | Deutsche Bank AG | |
| 13.03.14 | Rio Tinto buy | Deutsche Bank AG | |
| 12.03.14 | BP Equal-Weight | Morgan Stanley | |
| 12.03.14 | Shell (ex Royal Dutch Shell) Equal-Weight | Morgan Stanley | |
| 12.03.14 | Sky buy | UBS AG | |
| 11.03.14 | Rio Tinto buy | Citigroup Corp. | |
| 11.03.14 | Glencore buy | Citigroup Corp. | |
| 11.03.14 | Vodafone Group buy | UBS AG | |
| 11.03.14 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 10.03.14 | Sky buy | UBS AG | |
| 10.03.14 | Standard Chartered kaufen | Citigroup Corp. | |
| 10.03.14 | Vodafone Group buy | Citigroup Corp. | |
| 10.03.14 | BAT buy | Citigroup Corp. | |
| 10.03.14 | HSBC Neutral | Citigroup Corp. | |
| 10.03.14 | AstraZeneca neutral | Barclays Capital | |
| 10.03.14 | GSK Equal weight | Barclays Capital | |
| 10.03.14 | Glencore buy | Citigroup Corp. |